Anti-Cytokeratin 5 + 6 + 18 antibody [LP34]
- BOND RX™ Validated
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(14 Publications)
Mouse Recombinant Monoclonal Cytokeratin 5 antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 14 publications.
View Alternative Names
58 kDa cytokeratin, Cytokeratin-5, Keratin-5, Type-II keratin Kb5, CK-5, K5, KRT5, K6A, KRT6D, KRT6A, Cytokeratin-6A, Cytokeratin-6D, Keratin-6A, Type-II keratin Kb6, CK-6A, CK-6D, 58 kDa cytokeratin, Cytokeratin-5, Keratin-5, Type-II keratin Kb5, CK-5, K5, KRT5
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 5 + 6 + 18 antibody [LP34] (AB40)
Immunohistochemical analysis of paraffin-embedded human bladder carcinoma tissue labeling Cytokeratin 5 + 6 + 18 with ab40 at 0.085μg/ml, followed by a ready to use secondary. Positive staining on human bladder carcinoma tissue is observed. The section was incubated with ab40 for 30 mins at RT. The immunostaining staining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, followed by a ready to use secondary. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 5 + 6 + 18 antibody [LP34] (AB40)
Immunohistochemical analysis of paraffin-embedded human pancreatic carcinoma tissue labeling Cytokeratin 5 + 6 + 18 with ab40 at 0.085μg/ml, followed by a ready to use secondary. Positive staining on human pancreatic carcinoma tissue is observed. The section was incubated with ab40 for 30 mins at RT. The immunostaining staining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, followed by a ready to use secondary. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 5 + 6 + 18 antibody [LP34] (AB40)
Immunohistochemical analysis of paraffin-embedded human skin labeling Cytokeratin 5 + 6 + 18 with ab40 at 1/1000 dilution, followed by a ready to use secondary. Positive staining on human skin is observed. The section was incubated with ab40 for 30 mins at RT. The immunostaining staining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, followed by a ready to use secondary. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 5 + 6 + 18 antibody [LP34] (AB40)
Immunohistochemical analysis of paraffin-embedded human tonsil tissue labeling Cytokeratin 5 + 6 + 18 with ab40 at 0.085μg/ml, followed by a ready to use secondary. Positive staining on the epithelial cells of human tonsil tissue is observed. The section was incubated with ab40 for 30 mins at RT. The immunostaining staining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, followed by a ready to use secondary. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins.
- WB
Lab
Western blot - Anti-Cytokeratin 5 + 6 + 18 antibody [LP34] (AB40)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure times : Lane 1 : 15 secs; Lane 2-3 : 3 secs.
All lanes:
Western blot - Anti-Cytokeratin 5 + 6 + 18 antibody [LP34] (ab40) at 0.424 µg/mL
Lane 1:
HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 2:
MCF7 (human breast adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 3:
HepG2 (human hepatocellular carcinoma epithelial cell), whole cell lysate at 20 µg
Secondary
All lanes:
Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) at 1/10000 dilution
Observed band size: 45 kDa
false
- WB
Lab
Western blot - Anti-Cytokeratin 5 + 6 + 18 antibody [LP34] (AB40)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Cytokeratin 5 + 6 + 18 antibody [LP34] (ab40) at 1/1000 dilution
All lanes:
Human skin lysate at 20 µg
Secondary
All lanes:
Western blot - Anti-mouse IgG for IP (HRP) (<a href='/en-us/products/secondary-antibodies/mouse-igg-for-ip-hrp-ab131368'>ab131368</a>) at 1/1000 dilution
Observed band size: 58 kDa
false
Exposure time: 114s
Related conjugates and formulations (1)
-
Anti-Cytokeratin 5 + 6 + 18 antibody [LP34] - BSA and Azide free
Reactivity data
Product details
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (14)
Recent publications for all applications. Explore the full list and refine your search
International journal of molecular sciences 25: PubMed38791563
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of clinical laboratory analysis 36:e24697 PubMed36161346
2022
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 21:e48530 PubMed32003148
2020
Applications
Unspecified application
Species
Unspecified reactive species
Environment international 136:105510 PubMed32004873
2020
Applications
Unspecified application
Species
Unspecified reactive species
FEBS open bio 10:338-350 PubMed31823504
2020
Applications
Unspecified application
Species
Unspecified reactive species
Neurology and therapy 8:95-111 PubMed31833027
2019
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 38:e102345 PubMed31701556
2019
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2019:7536803 PubMed31781348
2019
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 38:e101064 PubMed31359456
2019
Applications
Unspecified application
Species
Unspecified reactive species
OncoTargets and therapy 12:5687-5699 PubMed31410016
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com